Back
Results - Announcements
Sales decline 34.49% to Rs 2.26 crore
Brawn Biotech reports standalone net loss of Rs 0.49 crore in the March 2025 quarter
27-May-2025, 07:40
Net Loss of Brawn Biotech reported to Rs 0.49 crore in the quarter ended March 2025 as against net loss of Rs 0.34 crore during the previous quarter ended March 2024. Sales declined 34.49% to Rs 2.26 crore in the quarter ended March 2025 as against Rs 3.45 crore during the previous quarter ended March 2024.
Net Loss of Brawn Biotech reported to Rs 0.49 crore in the quarter ended March 2025 as against net loss of Rs 0.34 crore during the previous quarter ended March 2024. Sales declined 34.49% to Rs 2.26 crore in the quarter ended March 2025 as against Rs 3.45 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 1.80 crore in the year ended March 2025 as against net loss of Rs 1.54 crore during the previous year ended March 2024. Sales declined 18.31% to Rs 13.47 crore in the year ended March 2025 as against Rs 16.49 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 2.26 | 3.45 | -34 | 13.47 | 16.49 | -18 |
| OPM % | -24.34 | -11.30 | - | -13.21 | -9.28 | - |
| PBDT | -0.46 | -0.31 | -48 | -1.69 | -1.44 | -17 |
| PBT | -0.49 | -0.34 | -44 | -1.80 | -1.54 | -17 |
| NP | -0.49 | -0.34 | -44 | -1.80 | -1.54 | -17 |
Powered by Capital Market - Live News